NEXMIF mutations in intellectual disability and epilepsy: A report of 2 cases and literature review.
10.11817/j.issn.1672-7347.2022.210070
- Author:
Shimeng CHEN
1
,
2
;
Xiaolu DENG
1
,
3
;
Juan XIONG
1
,
3
;
Baiyu CHEN
1
,
3
;
Fang HE
1
,
3
;
Lifen YANG
1
,
3
;
Li YANG
1
,
3
;
Jing PENG
1
,
3
;
Fei YIN
1
,
4
Author Information
1. Department of Pediatrics, Xiangya Hospital, Central South University
2. Research Center of Children Intellectual Disability of Hunan Province, Changsha 410008, China. 18890358210@163.com.
3. Research Center of Children Intellectual Disability of Hunan Province, Changsha 410008, China.
4. Research Center of Children Intellectual Disability of Hunan Province, Changsha 410008, China. yf2323@hotmail.com.
- Publication Type:Review
- Keywords:
NEXMIF gene;
epilepsy;
infantile spasm;
intellectual disability
- MeSH:
Child;
Epilepsy/genetics*;
Female;
Humans;
Intellectual Disability/genetics*;
Male;
Muscle Hypotonia/complications*;
Mutation;
Phenotype;
Seizures/genetics*;
Strabismus/complications*
- From:
Journal of Central South University(Medical Sciences)
2022;47(2):265-270
- CountryChina
- Language:English
-
Abstract:
More than 100 genes located on the X chromosome have been found to be associated with X-linked intellectual disability (XLID) to date, and NEXMIF is a pathogenic gene for XLID. In addition to intellectual disability, patients with NEXMIF gene mutation can also have other neurological symptoms, such as epilepsy, abnormal behavior, and hypotonia, as well as abnormalities of other systems. Two children with intellectual disability and epilepsy caused by NEXMIF gene mutation were treated in the Department of Pediatrics, Xiangya Hospital, Central South University from March 8, 2017 to June 20, 2020. Patient 1, a 7 years and 8 months old girl, visited our department because of the delayed psychomotor development. Physical examination revealed strabismus (right eye), hyperactivity, and loss of concentration. Intelligence test showed a developmental quotient of 43.6. Electroencephalogram showed abnormal discharge, and cranial imaging appeared normal. Whole exome sequencing revealed a de novo heterozygous mutation, c.2189delC (p.S730Lfs*17) in the NEXMIF gene (NM_001008537). During the follow-up period, the patient developed epileptic seizures, mainly manifested as generalized and absent seizures. She took the medicine of levetiracetam and lamotrigine, and the seizures were under control. Patient 2, a 6-months old boy, visited our department due to developmental regression and seizures. He showed poor reactions to light and sound, and was not able to raise head without aid. Hypotonia was also noticed. The electroencephalogram showed intermittent hyperarrhythmia, and spasms were monitored. He was given topiramate and adrenocorticotrophic hormone (ACTH). Whole exome sequencing detected a de novo c.592C>T (Q198X) mutation in NEXMIF gene. During the follow-up period, the seizures were reduced with vigabatrin. He had no obvious progress in the psychomotor development, and presented strabismus. There were 91 cases reported abroad, 1 case reported in China, and 2 patients were included in this study. A total of 85 variants in NEXMIF gene were found, involving 83 variants reported in PubMed and HGMD, and the 2 new variants presented in our patients. The patients with variants in NEXMIF gene all had mild to severe intellectual disability. Behavioral abnormalities, epilepsy, hypotonia, and other neurological symptoms are frequently presented. The phenotype of male partially overlaps with that of female. Male patients often have more severe intellectual disability, impaired language, and autistic features, while female patients often have refractory epilepsy. Most of the variants reported so far were loss-of-function resulted in the reduced protein expression of NEXMIF. The degree of NEXMIF loss appears to correlate with the severity of the phenotype.
